(Q34464035)

2 August 2017

title

NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor (English)

1 reference

2 August 2017

James L Ellis

1

1 reference

2 August 2017

Michael E Augustyniak

2

1 reference

2 August 2017

Edward D Cochran

3

1 reference

2 August 2017

Richard A Earl

4

1 reference

2 August 2017

David S Garvey

5

1 reference

2 August 2017

Laura J Gordon

6

1 reference

2 August 2017

David R Janero

7

1 reference

2 August 2017

Subhash P Khanapure

8

1 reference

2 August 2017

L Gordon Letts

9

1 reference

2 August 2017

Terry L Melim

10

1 reference

2 August 2017

Madhavi G Murty

11

1 reference

2 August 2017

David J Schwalb

12

1 reference

2 August 2017

Matthew J Shumway

13

1 reference

2 August 2017

William M Selig

14

1 reference

2 August 2017

A Mark Trocha

15

1 reference

2 August 2017

Delano V Young

16

1 reference

2 August 2017

Irina S Zemtseva

17

1 reference

2 August 2017

publication date

1 January 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

issue

5-6

1 reference

2 August 2017

page(s)

521-534

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Nitric oxide donors increase mucus gel thickness in rat stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Selective cyclooxygenase-2 inhibitors: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Clinical trials. Halt of Celebrex study threatens drug's future, other trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

First and second generations of COX-2 selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

The development of COX2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Nitric oxide: an endogenous modulator of leukocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

The nitric oxide-releasing naproxen derivative displays cardioprotection in perfused rabbit heart submitted to ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1163%2F156856005774382661

Nitric oxide in vascular biology

21 January 2018

2 references

https://api.crossref.org/works/10.1163%2F156856005774382661

21 January 2018

12 December 2020

The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions

1 reference

12 December 2020

Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells.

1 reference

12 December 2020

Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs

1 reference

12 December 2020

Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use

1 reference

12 December 2020

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

1 reference

12 December 2020

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial

1 reference

12 December 2020

10.1163/156856005774382661

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1026625650

0 references

1 reference